The Company

Our mission is to save lives by combining the benefits of genomics with artificial intelligence to provide a precision diagnosis for Antimicrobial Resistance

About AarogyaAI

Tuberculosis claims more lives every year than AIDS. This is because, of the 19 anti-TB drugs available, doctors don’t always know which ones will work for whom.

Thus, even though tuberculosis is curable, a delayed diagnosis of drug-resistant tuberculosis can mean patients are on ineffective medication for up to 7 years. Currently, there are no tools to diagnose drug-resistant tuberculosis quickly and comprehensively. AarogyaAI aims to diagnose drug-resistant tuberculosis in a few hours so that a patient can be prescribed effective treatment, instantly.

We use a DNA sequence from the patient which is uploaded to our SaaS. Our machine learning algorithm then gives an output report of the comprehensive drug susceptibility status of the patient.

In the long run, we will be able to predict the patterns of evolution of the bacteria and future drug resistance patterns. Our data analytics dashboard will provide valuable insight into bacterial phylogeny, its geographical influences amongst other statistics. This would greatly benefit public health programs in strategically placing PHCs as well as pharma companies to improve supply chain logistics and drug development.


Our co-founders, Praapti and Avlokita, are motivated by their life experiences to develop a solution for the growing challenges of DR-TB.

Praapti, grew up in a family of doctors and was motivated to address public health issues using her scientific training in infectious diseases.

Avlokita, lost her grandmother to tuberculosis and wanted to be a part of the solution working towards eliminating this disease.

In India today, Tuberculosis affects nearly 2.7 million people each year, and thousands of people die because of it. However, there is a disproportionate focus on solving micro problems in research which, do not translate into public application. Our aim is to bridge that gap.

As a young start-up in the space of healthcare technology, we have drawn on the experiences of our peers and relied on this growing community of entrepreneurs to navigate complexities in compliances, IP laws and taxes for startups in India. Through this community, we have also had the opportunity to share our vision, our story and where we want to go from here. We are greatly inspired by Dr. Soumya Swaminathan, Chief Scientist at WHO and a tuberculosis physician. Dr. Swaminathan took a keen interest in our objectives and, is our mentor on this journey.

Contact Us

praapti(at) avlokita(at)